Alphabet Inc. Verve Therapeutics, Inc. Transaction History
Alphabet Inc.
- $1.12 Billion
- Q1 2025
A detailed history of Alphabet Inc. transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Alphabet Inc. holds 12,349,086 shares of VERV stock, worth $63.7 Million. This represents 5.03% of its overall portfolio holdings.
Number of Shares
12,349,086
Previous 12,349,086
-0.0%
Holding current value
$63.7 Million
Previous $69.6 Million
18.97%
% of portfolio
5.03%
Previous 4.92%
Shares
3 transactions
Others Institutions Holding VERV
# of Institutions
188Shares Held
76.1MCall Options Held
70.3KPut Options Held
194K-
Bvf Inc San Francisco, CA6.9MShares$35.6 Million1.46% of portfolio
-
Black Rock Inc. New York, NY6.62MShares$34.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.01MShares$20.7 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY4MShares$20.6 Million1.94% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.92MShares$20.2 Million0.01% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $309M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...